Nipro Corp
TSE:8086
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 136.5
1 498.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Nipro Corp
Nipro Corp
Cost of Revenue
Nipro Corp
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nipro Corp
TSE:8086
|
Cost of Revenue
-¥433.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Hoya Corp
TSE:7741
|
Cost of Revenue
-¥114.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
Cost of Revenue
-¥26.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Shofu Inc
TSE:7979
|
Cost of Revenue
-¥15.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
|
Menicon Co Ltd
TSE:7780
|
Cost of Revenue
-¥55.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Mani Inc
TSE:7730
|
Cost of Revenue
-¥10.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
Nipro Corp
Glance View
Nipro Corporation, a prominent player in the medical industry, began as a humble glass-tubing business in the heart of Japan in 1954. Over the decades, it metamorphosed into a sprawling conglomerate with a nuanced focus on healthcare. Today, Nipro is intricately woven into the fabric of the medical supply chain. Its products range from dialysis equipment to diabetes care and even medical glass products, evidencing a broad spectrum of specialties. This diversification is not simply an expansion but a strategic integration that enables the company to leverage its expertise across related domains, ensuring resilience in the ever-evolving healthcare market. The engine powering Nipro’s business model lies in its vertical integration and global footprint. By manufacturing an array of products internally, from raw materials like glass and plastics to final medical devices, Nipro maintains stringent quality control and cost efficiencies. Beyond Japan, the company has established a significant presence in over 50 countries, tapping into diverse markets with its extensive portfolio. Strategic partnerships and mergers further bolster its global expansiveness, enhancing its distribution networks. The seamless intersection of innovation, quality, and market reach solidifies Nipro's stature as a leading entity in healthcare solutions, driving its sustained financial performance.
See Also
What is Nipro Corp's Cost of Revenue?
Cost of Revenue
-433.1B
JPY
Based on the financial report for Sep 30, 2024, Nipro Corp's Cost of Revenue amounts to -433.1B JPY.
What is Nipro Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-7%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Nipro Corp have been -9% over the past three years , -7% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet